Intravenous immunoglobulin treatment for fibrosis, atherosclerosis, and malignant conditions.

I. Krause,Y. Shoenfeld
DOI: https://doi.org/10.1385/1-59259-862-5:403
Abstract:
What problem does this paper attempt to address?